OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Noy on the Rationale to Evaluate Devimistat in Burkitt Lymphoma

December 19th 2019

Ariela Noy, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the rationale to evaluate devimistat (CPI-613) in patients with either Burkitt lymphoma/leukemia or high-grade B-cell lymphoma.

Dr. Kim on Immunotherapy in CRC

December 18th 2019

Richard Kim, MD, discusses the use of immunotherapy in colorectal cancer.

Dr. Hellmann on Evolution of Surgical Techniques in Endometrial Cancer

December 18th 2019

Mira Hellmann, MD, gynecologic oncologist and assistant professor, John Theurer Cancer Center, Hackensack University Medical Center, discusses the evolution of surgical techniques in endometrial cancer.

Dr. Kruse on How to Converse About Biosimilars in Breast Cancer

December 18th 2019

Megan Kruse, MD, discusses how to converse with patients with breast cancer about implementing biosimilars in treatment.

Dr. Gralow on the Science of Biosimilars and Implementation in Breast Cancer

December 18th 2019

Julie R. Gralow, MD, discusses the science of biosimilars and their implementation in breast cancer.

Dr. Benson on Treatment for Patients With Resectable Colorectal Cancer

December 18th 2019

Al B. Benson, MD, professor of medicine, Hematology and Oncology, Northwestern University Feinberg School of Medicine, discusses treatment for patients with resectable colorectal cancer (CRC).

Dr. O'Reilly on Investigational Treatment Approaches in Pancreatic Cancer

December 18th 2019

Eileen O'Reilly, MD, associate director for clinical research and medical oncologist at Memorial Sloan Kettering Cancer Center, discusses investigational treatment approaches in advanced pancreatic cancer.

Dr. Cosgrove on Retreatment With PARP Inhibitors in Ovarian Cancer

December 18th 2019

Casey M. Cosgrove, MD, gynecologic oncologist, The Ohio State University Comprehensive Cancer Center–James, and assistant professor, Department of Gynecologic Oncology, The Ohio State University College of Medicine, discusses retreatment with PARP inhibitors in recurrent ovarian cancer.

Dr. Liu on the CheckMate-032 Trial in SCLC

December 17th 2019

Stephen Liu, MD, discusses the CheckMate-032 trial in small cell lung cancer.

Dr. Hidalgo Medina on MSI and Germline Testing in Pancreatic Cancer

December 17th 2019

Manuel Hidalgo Medina, MD, PhD, discusses microsatellite instability and germline testing patients with pancreatic cancer.

Dr. Eng on Addressing Unmet Needs for Colorectal Cancer

December 17th 2019

Cathy Eng, MD, FACP, FASCO, discusses ways to address unmet needs for young adults with colorectal cancer.

Dr. Ferguson on Minimally Invasive Vs Open Surgery for Radical Hysterectomy in Cervical Cancer

December 17th 2019

Sarah Ferguson, MD, FRCSC, discusses the rationale to conduct a population-based cohort study comparing the efficacy of minimally invasive surgery versus open surgery for radical hysterectomy in women with cervical cancer.

Dr. Cristofanilli on the Need for Biosimilars in Oncology

December 16th 2019

Massimo Cristofanilli, MD, discusses the need for biosimilars in oncology.

Dr. Fidler on the Utility of Dacomitinib in EGFR-Mutant NSCLC

December 16th 2019

Mary J. Fidler, MD, discusses the utility of dacomitinib (Vizimpro) in patients with EGFR-mutant non–small cell lung cancer.

Dr. Hays on Combining PARP Inhibitors With Immunotherapy in Ovarian Cancer

December 16th 2019

John Hays, MD, PhD, discusses investigational combinations of PARP inhibitors and immunotherapy in ovarian cancer.

Dr. Park on Potential Alternate CAR T-Cell Targets in B-Cell Malignancies

December 14th 2019

Jae H.Park, MD, discusses potential alternate CAR T-cell targets in B-cell malignancies.

Dr. Danilov on Utility of Rituximab Biosimilars in CLL

December 14th 2019

Alexey V. Danilov, MD, PhD, discusses the utility of rituximab biosimilars in chronic lymphocytic leukemia.

Dr. McQuade on Age as a Predictor of Response to Neoadjuvant Immunotherapy in Melanoma

December 14th 2019

Jennifer McQuade, MD, MS, MA, LAc, discusses how age may serve as a predictor of response to neoadjuvant immunotherapy for patients with melanoma.

Characteristics, Healthcare Utilization, and Costs of Medicare Patients Receiving CAR T-Cell Therapy

December 13th 2019

Karl M. Kilgore, PhD, senior research scientist, Avalere Health, discusses real-world data regarding Medicare patients with non-Hodgkin lymphoma receiving CAR T-cell therapy.

Dr. Pagel on Biosimilars and Cost Consciousness in Oncology

December 13th 2019

John M. Pagel, MD, PhD, discusses the use of biosimilars in oncology and the importance of cost consciousness.